losartan has been researched along with ethyl cellulose in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC; Ho, HO; Hsieh, CM; Hung, SF; Sheu, MT; Wang, YC | 1 |
| -Ur-Rehman, F; Ahmad, A; Jan, SU; Khan, GM; Khan, H; Khan, KA; Niazi, ZR; Shah, KU; Shah, PA; Tahir, M; Ullah, A | 1 |
| Fazli, AA; Khan, NA; Raza, SN; Sheikh, FA; Wani, TU | 1 |
3 other study(ies) available for losartan and ethyl cellulose
| Article | Year |
|---|---|
Characterizations of plasticized polymeric film coatings for preparing multiple-unit floating drug delivery systems (muFDDSs) with controlled-release characteristics.
Topics: Cellulose; Delayed-Action Preparations; Drug Carriers; Losartan; Membranes, Artificial; Plastics; Sodium Bicarbonate; Stress, Mechanical | 2014 |
Design, Preparation and evaluation of various parameters of controlled release matrices of losartan potassium using polymers combination.
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Cellulose; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Compounding; Drug Liberation; Excipients; Kinetics; Losartan; Models, Chemical; Solubility; Tablets | 2020 |
Formulation and Pharmacokinetic Evaluation of Ethyl Cellulose/HPMC-Based Oral Expandable Sustained Release Dosage of Losartan Potassium.
Topics: Animals; Biological Availability; Cellulose; Delayed-Action Preparations; Losartan; Rabbits | 2022 |